These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10382114)

  • 1. Solubility behaviour of haloperidol in individual solvents determination of partial solubility parameters.
    Subrahmanyam CV; Suresh S
    Eur J Pharm Biopharm; 1999 May; 47(3):289-94. PubMed ID: 10382114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended Hansen's solubility approach: meloxicam in individual solvents.
    Babu PR; Subrahmanyam CV; Thimmasetty J; Manavalan R; Valliappan K
    Pak J Pharm Sci; 2007 Oct; 20(4):311-6. PubMed ID: 17604255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the solubility of sulfamethoxypyridazine in individual solvents. I: Calculating partial solubility parameters.
    Bustamante P; Escalera B; Martin A; Sellés E
    J Pharm Sci; 1989 Jul; 78(7):567-73. PubMed ID: 2778657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the solubility of sulfamethoxypyridazine in individual solvents. II: Relationship between solute-solvent interaction terms and partial solubility parameters.
    Martin A; Bustamante P; Escalera B; Sellés E
    J Pharm Sci; 1989 Aug; 78(8):672-8. PubMed ID: 2778673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expanded Hansen approach to solubility parameters. Paracetamol and citric acid in individual solvents.
    Barra J; Lescure F; Doelker E; Bustamante P
    J Pharm Pharmacol; 1997 Jul; 49(7):644-51. PubMed ID: 9255705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanded solubility parameter approach. I: Naphthalene and benzoic acid in individual solvents.
    Beerbower A; Wu PL; Martin A
    J Pharm Sci; 1984 Feb; 73(2):179-88. PubMed ID: 6707879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial solubility parameters and solvatochromic parameters for predicting the solubility of single and multiple drugs in individual solvents.
    Bustamante P; Martin A; Gonzalez-Guisandez MA
    J Pharm Sci; 1993 Jun; 82(6):635-40. PubMed ID: 8331539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of Solubility Parameters of Ibuprofen and Ibuprofen Lysinate.
    Kitak T; Dumičić A; Planinšek O; Šibanc R; Srčič S
    Molecules; 2015 Dec; 20(12):21549-68. PubMed ID: 26633347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended Hansen approach: calculating partial solubility parameters of solid solutes.
    Wu PL; Beerbower A; Martin A
    J Pharm Sci; 1982 Nov; 71(11):1285-7. PubMed ID: 7175725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded solubility parameter approach. II: p-Hydroxybenzoic acid and methyl p-hydroxybenzoate in individual solvents.
    Martin A; Wu PL; Beerbower A
    J Pharm Sci; 1984 Feb; 73(2):188-94. PubMed ID: 6707880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of partial solubility parameters of five benzodiazepines in individual solvents.
    Verheyen S; Augustijns P; Kinget R; Van den Mooter G
    Int J Pharm; 2001 Oct; 228(1-2):199-207. PubMed ID: 11576782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial solubility parameters of lactose, mannitol and saccharose using the modified extended Hansen method and evaporation light scattering detection.
    Peña MA; Daali Y; Barra J; Bustamante P
    Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):179-83. PubMed ID: 10705501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between swelling of hydroxypropylmethylcellulose and the Hansen and Karger partial solubility parameters.
    Navarro-Lupión FJ; Bustamante P; Escalera B
    J Pharm Sci; 2005 Jul; 94(7):1608-16. PubMed ID: 15920774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The modified extended Hansen method to determine partial solubility parameters of drugs containing a single hydrogen bonding group and their sodium derivatives: benzoic acid/Na and ibuprofen/Na.
    Bustamante P; Pena MA; Barra J
    Int J Pharm; 2000 Jan; 194(1):117-24. PubMed ID: 10601690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the solubility of drugs in solvent mixtures: multiple solubility maxima and the chameleonic effect.
    Escalera JB; Bustamante P; Martin A
    J Pharm Pharmacol; 1994 Mar; 46(3):172-6. PubMed ID: 8027922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposition of group molar constants for sodium to calculate the partial solubility parameters of sodium salts using the van Krevelen group contribution method.
    Barra J; Peña MA; Bustamante P
    Eur J Pharm Sci; 2000 Apr; 10(2):153-61. PubMed ID: 10727881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended Hansen solubility approach: naphthalene in individual solvents.
    Martin A; Wu PL; Adjei A; Beerbower A; Prausnitz JM
    J Pharm Sci; 1981 Nov; 70(11):1260-4. PubMed ID: 7299673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the phase behavior in mixtures of pharmaceuticals with liquid or supercritical solvents.
    Tsivintzelis I; Economou IG; Kontogeorgis GM
    J Phys Chem B; 2009 May; 113(18):6446-58. PubMed ID: 19368360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method to determine the partial solubility parameters of polymers from intrinsic viscosity.
    Bustamante P; Navarro-Lupión J; Escalera B
    Eur J Pharm Sci; 2005 Feb; 24(2-3):229-37. PubMed ID: 15661495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of solubility parameters for poly(3-hydroxyalkanoates).
    Terada M; Marchessault RH
    Int J Biol Macromol; 1999; 25(1-3):207-15. PubMed ID: 10416669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.